Tuesday, September 9, 2008

FDA Issues Warning Letter for Forest Laboratories' Bystolic Tablets

The FDA posted on its web site a warning letter to Forest Laboratories, Inc. about a journal ad for its hypertension treatment Bystolic (nebivolol) Tablets.

The details can be read here.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)